Kowalsky Matthew Paul

person

Unified public record assembled from the source systems listed below. Amounts describe distinct reported activity and are not added into a single influence total.

Political giving

—

Political receipts

—

Lobbying income

—

Lobbying expense

—

Federal awards

—

Relationships

Connected records

Relationship	Connected entity	Amount / weight	Period
insider of	Protara Therapeutics, Inc.	39,038.84	Jun 30, 2017 – Jan 18, 2019
insider of	Inc. Enanta Pharmaceuticals	27,103.5	Apr 29, 2024 – Feb 12, 2026
insider of	Sigilon Therapeutics, Inc.	9,517.5	Feb 28, 2023 – Aug 11, 2023

Source coverage

sec insider: 0001705824

Kowalsky Matthew Paul — Influence Profile | Poliscope